AGREEMENTAgreement • March 16th, 2017 • Agenus Inc • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledMarch 16th, 2017 Company Industry JurisdictionAGREEMENT made and entered into in Lexington, MA, by and between Agenus Inc. (the “Company”), a Delaware corporation with a principal place of business at 3 Forbes Rd. Lexington, MA 02421, and Jean-Marie Cuillerot, MD (the “Executive”), effective as of this 10th day of March, 2017 (the “Effective Date”) (the “Agreement”). Words or phrases which are initially capitalized or are within quotation marks shall have the meanings provided in Section 14 below and as provided elsewhere herein.
AGREEMENTAgreement • June 30th, 2015 • Agenus Inc • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledJune 30th, 2015 Company Industry JurisdictionAGREEMENT made and entered into in Lexington, MA, by and between Agenus Inc. (the “Company”), a Delaware corporation with a principal place of business at 3 Forbes Rd. Lexington, MA 02421, and Robert B. Stein (the “Executive”), effective as of the 30th day of June, 2015 (the “Effective Date”) (the “Agreement”). Words or phrases which are initially capitalized or are within quotation marks shall have the meanings provided in Section 14 below and as provided elsewhere herein.
AGREEMENTAgreement • September 19th, 2008 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledSeptember 19th, 2008 Company Industry JurisdictionAGREEMENT made and entered into in New York, New York, by and between Antigenics Inc. (the “Company”), a Delaware corporation with a principal place of business at 162 Fifth Ave Suite 900 New York, NY, and Karen Higgins Valentine (the “Executive”), effective as of the 16th day of September, 2008 (the “Effective Date”) (the “Agreement”). Words or phrases which are initially capitalized or are within quotation marks shall have the meanings provided in Section 14 below and as provided elsewhere herein.